Dallas, Texas (PRWEB) June 11, 2014
The North American Interventional cardiology and peripheral vascular devices market are expected to grow at a CAGR of 2.9% from 2013 to 2018. Both, the lower volume of coronary angioplasty procedures and the increasing prevalence rate of peripheral artery diseases have impacted the market significantly.
Company Profiles included in this study are Abbott Laboratories, B. Braun Melsungen Ag, Biotronik Se & Co. Kg, Boston Scientific Corporation, Cook Medical, Inc., Cordis Corporation, Covidien Plc, C. R. Bard, Inc., W.L.Gore & Associates, Inc. And Medtronic Inc.
Amongst all the product segments, bioabsorbable stents, retrievable inferior vena cava filters, and diagnostic catheters (intravascular ultrasound and optical coherence tomography catheters) markets are identified as the high growth segments in the North American interventional cardiology and peripheral vascular devices market. Better diagnosis of thrombus using IVUS and OCT catheters is expected to drive the diagnostic catheters market; whereas, lesser risk of long-term post surgical complications in DVT/PE treatments will encourage faster adoption of the retrievable inferior vena cava filters in the coming years. The bioabsorbable stents are still not available for clinical usage in the U.S. However, bioabsorbable stents are available on a special access basis by Health Canada.
The usage factors of different surgical instruments were the major hindrances while deriving the market size of the corresponding surgical devices. This is primarily due to the availability of various surgical instruments for the treatment of similar cardiac ailments. For instance, coronary angioplasty can be performed through plain balloon catheter, stent, and/or a combination of stent and catheter, based on patients’ cardiac health. Place a direct purchase order @ http://www.reportsnreports.com/Purchase.aspx?name=288020.
The study on the North American interventional cardiology and peripheral vascular devices market captures an exhaustive list of surgical devices which are used in various types of angioplasty procedures, deep vein thrombosis, endovascular aneurysm repairing, and chronic total occlusion (CTO) treatment procedures. This research illustrates specific driving and restraining factors in the U.S. and Canadian markets; furthermore, it identifies the high-growth regions with regard to the interventional cardiology and peripheral vascular devices market. This extensive study provides an analytical comparison of the key players in terms of their segmental revenue and related portfolio and their respective market shares in the U.S. and Canadian market spaces in 2013. In a nutshell, this research intends to capture all facets of the North American interventional cardiology and peripheral vascular devices market to put forward approachable market solutions for leading players as well as new entrants.
Request a Sample @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=288020.
Table of Contents
2 Executive Summary
3 Premium Insights
4 Market Overview
5 Angioplasty Balloons
6 Angioplasty Stents
7 Catheters Market
8 Endovascular Aneurysm Repair (EVAR) Stent Grafts Market
9 Inferior Vena Cava (IVC) Filters Market
10 Plaque Modification Devices Market
11 Hemodynamic Flow Alteration Devices Market
12 Accessory Devices Market
13 Geographic Analysis
14 Competitive Landscape
15 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)
List of Tables
Inquire for DISCOUNT offered @ http://www.reportsnreports.com/contacts/Discount.aspx?name=288020.
ReportsnReports.com is an online market research reports library of 350,000+ in-depth studies of over 5000 micro markets. We provide 24/7 online and offline support service to our customers.